Loading clinical trials...
Loading clinical trials...
Carbapenem-resistant Enterobacteriaceae (CRE) are increasingly identified in children in China. Pediatric intensive care unit (PICU) is the high-risk area. However, data on the epidemiology of CRE in ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Children's Hospital of Fudan University
NCT07086391 · Carbapenem-Resistant Enterobacteriaceae Infection, Pneumonia - Bacterial
NCT05871476 · Antibiotic Resistant Infection, Carbapenem-Resistant Enterobacteriaceae Infection
NCT04014413 · Crohn Disease, Ulcerative Colitis, and more
NCT03924934 · Enterobacteriaceae Infections, Community-Acquired Infections, and more
NCT05981430 · Carbapenem-Resistant Enterobacteriaceae Infection, Fecal Microbiota Transplantation
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions